How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.

Autor: Burden‐Teh, E., Lam, M.L., Taibjee, S.M., Taylor, A., Webster, S., Dolman, S., Jury, C., Caruana, D., Darne, S., Carmichael, A., Natarajan, S., McPherson, T., Moore, A., Katugampola, R., Kalavala, M., Al‐Ismail, D., Richards, L., Jones, V., Batul Syed, S., Glover, M.
Předmět:
Zdroj: British Journal of Dermatology; Aug2015, Vol. 173 Issue 2, p614-618, 5p
Abstrakt: The article discusses research into the British clinical practice involving the use of systemic agents for treating children with psoriasis. Topics explored include the lack of national guidance for the therapeutic application of these agents, the pretreatment screening procedures which consist of blood tests and chest X-ray, and the patient outcomes and adverse events recorded following treatment.
Databáze: Complementary Index